Once-Weekly Basal Insulin Nears Market for Type 2 Diabetes

Small increases in hypoglycemia were seen with icodec versus other basal insulins but overall rates were low.
Medscape Medical News

source https://www.medscape.com/viewarticle/993734?src=rss